Simon H. Stertzer's most recent trade in BioCardia Inc. was a trade of 72,289 Common Stock done at an average price of $2.1 . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioCardia Inc | Simon H. Stertzer | Director | Purchase of securities on an exchange or from another person at price $ 2.08 per share. | 30 Jun 2025 | 72,289 | 192,654 (2%) | 1% | 2.1 | 150,000 | Common Stock |
| BioCardia Inc | Simon H. Stertzer | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Jun 2025 | 72,289 | 177,275 | - | - | Warrant (right to buy) | |
| BioCardia Inc | Simon H. Stertzer | Director | Purchase of securities on an exchange or from another person at price $ 1.90 per share. | 23 Apr 2025 | 104,986 | 120,365 (1%) | 1% | 1.9 | 199,998 | Common Stock |
| BioCardia Inc | Simon H. Stertzer | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Apr 2025 | 104,986 | 104,986 | - | - | Warrant (right to buy) | |
| BioCardia Inc | Simon H. Stertzer | Director | Purchase of securities on an exchange or from another person at price $ 2.45 per share. | 05 Mar 2025 | 1,000 | 57,138 (0%) | 0% | 2.5 | 2,450 | Common Stock |
| BioCardia Inc | Simon H. Stertzer | Director | Purchase of securities on an exchange or from another person at price $ 2.30 per share. | 03 Mar 2025 | 22,753 | 40,602 (0%) | 0% | 2.3 | 52,332 | Common Stock |
| BioCardia Inc | Simon H. Stertzer | Director | Purchase of securities on an exchange or from another person at price $ 2.30 per share. | 03 Mar 2025 | 15,536 | 56,138 (0%) | 0% | 2.3 | 35,733 | Common Stock |
| BioCardia Inc | Simon H. Stertzer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2024 | 829 | 3,573 | - | - | Stock Option (right to buy) | |
| BioCardia Inc | Simon H. Stertzer | Director | Grant, award, or other acquisition of securities at price $ 2.34 per share. | 23 Jun 2023 | 64,212 | 267,766 (3%) | 0% | 2.3 | 149,999 | Common Stock |
| BioCardia Inc | Simon H. Stertzer | Director | Grant, award, or other acquisition of securities at price $ 1.68 per share. | 16 Dec 2022 | 178,571 | 888,084 (13%) | 2% | 1.7 | 299,999 | Common Stock |
| BioCardia Inc | Simon H. Stertzer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 12,434 | 35,076 | - | - | Stock Option (right to buy) | |
| BioCardia Inc | Simon H. Stertzer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 12,434 | 22,642 | - | - | Stock Option (right to buy) | |
| BioCardia Inc | Simon H. Stertzer | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 2,304 | 203,554 (2%) | 0% | 0 | Common Stock | |
| BioCardia Inc | Simon H. Stertzer | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 2,968 | 195,482 (2%) | 0% | 0 | Common Stock |